Related Experiment Videos
Classification of acute leukaemias
1Department of Haematological Medicine, University Clinical School, Cambridge, UK.
Blood Reviews
|September 1, 1988
Summary
The FAB classification for acute leukaemias (ALL and AML) has limitations. New approaches using cell markers, genetics, and differentiation are proposed for improved classification.
Area of Science:
- Hematology
- Oncology
- Cell Biology
Background:
- Traditional acute leukaemia classification relies on cytomorphology and cytochemistry.
- The FAB (French-American-British) L1-L3 (ALL) and M1-M7 (AML) system has been widely used.
- Criticisms of the FAB system highlight the need for more comprehensive classification methods.
Purpose of the Study:
- To critically evaluate the existing FAB classification for acute leukaemias.
- To explore novel approaches for leukaemia classification, including multiple lineage expression, cell differentiation markers, isoenzyme biochemistry, and cytogenetics.
- To propose a simplified, yet adaptable, classification system for acute leukaemias.
Main Methods:
- Review and critique of the FAB classification system.
- Discussion of emerging classification criteria: multiple lineage expression, cytochemical differentiation, isoenzyme analysis, immunophenotyping with monoclonal antibodies, and cytogenetics.
- Illustration of complex, combined classification systems.
- Proposal of a simplified classification framework.
Main Results:
- The FAB classification, while historically significant, presents limitations in accurately categorizing all acute leukaemias.
- Multiple biological features, including surface antigens, cytogenetics, and cell differentiation markers, offer valuable insights beyond traditional morphology.
- A simplified classification is proposed, stratifying ALL by antigenic and cytogenetic profiles, and AML by morphology and cytochemistry.
Conclusions:
- The traditional FAB classification requires augmentation with newer biological data for precise acute leukaemia categorization.
- A refined classification integrating immunophenotyping and cytogenetics for ALL, and morphology/cytochemistry for AML, offers a more robust approach.
- The proposed simplified classification provides a flexible framework for further elaboration and clinical application in acute leukaemia diagnosis and management.